
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
Ramesh Raju Mavuleti*, [email protected], is head of operations, Validation Services India, at Merck Life Sciences Pvt, Ltd.

Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.

The evolution of therapeutic modalities drives the adoption of single-use technologies.

March 15th 2024